The Burden of Multiple Basal Cell Carcinomas: A Population-wide Study
- PMID: 38803206
- PMCID: PMC11151493
- DOI: 10.2340/actadv.v104.40112
The Burden of Multiple Basal Cell Carcinomas: A Population-wide Study
Abstract
Basal cell carcinoma (BCC) is a common skin cancer type and affected individuals are known to be at risk of developing multiple consecutive tumours. Research into BCC multiplicity has, thus far, been challenging, due to a lack of national registration. This registry-based cohort study aimed to analyse the occurrence of multiple BCCs in Sweden, and risk factors for subsequent primary BCCs. Data regarding all histopathologically verified, primary BCC tumours in Sweden from 2004 to 2017 was extracted from the Swedish BCC Registry. Risk of developing a subsequent BCC in relation to person-related factors was estimated with Cox regression analysis. Cumulative risk of BCC development after 1 or 3 earlier BCCs was estimated. In total, 39.9% of individuals with a registered BCC had at least 2 registered tumours. The risk of developing a subsequent BCC increased significantly in males, older age, and with residence in southern Sweden. The cumulative 5-year risk of developing an additional BCC after first diagnosis was approximately 30% in males and 27% in females and increased after multiple previous BCCs. This study showed the cumulative risk of a subsequent BCC to increase with a history of multiple BCCs, indicating the need for clinical surveillance in these individuals.
Conflict of interest statement
JK has received speaker honoraria from Galderma Sweden and Sanofi Sweden. ÅI has received speaker honoraria from Galderma Sweden, Perrigo Sweden, and Biofrontera Sweden. KN has received speaker honoraria from Galderma Sweden, LEO Pharma, Novartis Sweden, and UCB Pharma and has served on one advisory board for MSD. The companies did not influence the study’s design, data collection, analysis, interpretation, or reporting.
Figures


Similar articles
-
Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regions.Arch Dermatol. 2012 Mar;148(3):347-54. doi: 10.1001/archdermatol.2011.2244. Arch Dermatol. 2012. PMID: 22431775
-
Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands.Br J Dermatol. 2011 Oct;165(4):874-81. doi: 10.1111/j.1365-2133.2011.10488.x. Br J Dermatol. 2011. PMID: 21711333
-
Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.JAMA Dermatol. 2020 Nov 1;156(11):1192-1198. doi: 10.1001/jamadermatol.2020.2571. JAMA Dermatol. 2020. PMID: 32845319 Free PMC article.
-
A nationwide study of the incidence and trends of first and multiple basal cell carcinomas in the Netherlands and prediction of future incidence.Br J Dermatol. 2022 Mar;186(3):476-484. doi: 10.1111/bjd.20871. Epub 2021 Dec 27. Br J Dermatol. 2022. PMID: 34726263
-
Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines.Eur J Cancer. 2019 Sep;118:10-34. doi: 10.1016/j.ejca.2019.06.003. Epub 2019 Jul 6. Eur J Cancer. 2019. PMID: 31288208 Review.
References
-
- Verkouteren JA, Ramdas KH, Wakkee M, Nijsten T. Epidemiology of basal cell carcinoma: scholarly review. Br J Dermatol 2017; 177: 359–372. - PubMed
-
- Gordon LG, Rowell D. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review. Eur J Cancer Prev 2015; 24: 141–149. - PubMed
-
- Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166: 1069–1080. - PubMed
-
- de Vries E, Micallef R, Brewster DH, Gibbs JH, Flohil SC, Saksela O, et al. . Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regions. Arch Dermatol 2012; 148: 347–354. - PubMed
-
- Kappelin J, Green AC, Ingvar A, Ahnlide I, Nielsen K. Incidence and trends of basal cell carcinoma in Sweden: a population-based registry study. Br J Dermatol 2022; 186: 963–969. - PubMed
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical